A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

This study is looking at how a drug called eloralintide (LY3841136) behaves in the body in people with severely reduced kidney function or kidney failure, compared to people with normal kidneys. The goal is to understand if kidney disease affects how the drug is processed, so that appropriate dosing can be established. **You may be eligible if...** - You weigh 55 kg or more and have a BMI between 19.0 and 40.0 kg/m² - You have no history of low blood sugar episodes - For the healthy group: your kidneys function normally (eGFR ≥ 90 mL/min) and your HbA1c is 6.5% or below - For the kidney impairment group: you have severe chronic kidney disease (eGFR < 30 mL/min) or end-stage kidney disease on dialysis **You may NOT be eligible if...** - You have a history of unexplained low blood sugar - Your BMI or weight falls outside the required range - Your kidney function does not match the group requirements Talk to your doctor to see if this trial is right for you.